Results 181 to 190 of about 6,040 (212)

Rimonabant: depression and suicide.

Prescrire international, 2009
Pharmacovigilance has revealed hundreds of reports of neuropsychiatric disorders and several deaths by suicide.
openaire   +1 more source

An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

Journal of Clinical Pharmacy and Therapeutics, 2011
D N Kiortsis
exaly  

Rimonabant ☆

2017
openaire   +1 more source

Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716)

European Journal of Neuroscience, 2009
Aaron N A Verty, Iain S Mcgregor, Brian J Oldfield   +2 more
exaly  

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

International Journal of Cancer, 2009
Antonietta Santoro, Simona Pisanti, Angelo A Izzo   +2 more
exaly  

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Lancet, The, 2005
Luc F Van Gaal, André J Scheen, Stephan Rossner   +2 more
exaly  

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

Basic Research in Cardiology, 2009
Shiang Y Lim, Sean M Davidson, Christopher C T Smith   +2 more
exaly  

Rimonabant: Unique and Promising

Preventive Cardiology, 2005
openaire   +2 more sources

RIMONABANT

2014
openaire   +1 more source

Rimonabant during early pregnancy

International Journal of Gynecology & Obstetrics, 2010
Guillaume, Ducarme, Pierre-François, Ceccaldi, Hélène, Pejoan, Dominique, Luton   +3 more
openaire   +2 more sources